Chinese company says coronavirus vaccine ready by early 2021

14 Sept 02:18 Key points summarised by AI

SinoVac, a Chinese pharmaceutical company, projects its CoronaVac vaccine will be ready for global distribution, including the U.S., by early 2021.
The company is conducting large-scale Phase 3 clinical trials in multiple countries like Brazil, Turkey, and Indonesia, involving over 24,000 participants.
SinoVac intends to apply to the U.S. FDA for approval and aims to produce hundreds of millions of doses by February or March next year, having already administered the vaccine to thousands in China under emergency use provisions.

Suchada: Meet the reluctant star of Thailand’s cryptic crypto drama

Yesterday 15:38 Key points summarised by AI

Thai MP Suchada Zhang Thaensap faces intense scrutiny over her husband’s substantial 1.84 billion baht wealth, with opposition lawmakers alleging connections to international scam networks.
A significant portion of her husband, Taiyang Zhang's, declared assets includes a 1.44 billion baht loan to the now-bankrupt cryptocurrency hedge fund Three Arrows Capital, which still owes him 1.34 billion baht.
Opposition MP Rangsiman Rome accused Suchada's husband of links to online scam networks and gambling sites, prompting Suchada to vehemently deny the claims, demand evidence, and file a defamation complaint.
Taiyang Zhang's background includes co-founding Ren Protocol, later sold to Alameda Research (linked to the FTX collapse), and some of his former associates have been convicted in crypto company failures.
Suchada, a former actress and first-time MP, maintains her husband's innocence, while her party leaders have distanced themselves from the allegations, deeming it a private matter.